TK
Tirunilayi Krishnan Venugopal
About Tirunilayi Krishnan Venugopal
Data last updated:
Tirunilayi Krishnan Venugopal is a Managing Director at Rhine Biogenics Private Limited (since 2003), Director at Rineus Health Care Company Private Limited (since 2013) and Director at Renolife Pharma (India) Private Limited (since 2010), and holds 2 more current directorships. The companies operate in Pharma and Healthcare. The 5 current companies with reported revenue have a combined latest revenue of ₹79.04 Cr; the largest is Rhine Biogenics Private Limited at ₹53.20 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Rhine Biogenics Private Limited U24232KL2003PTC016519 | Managing Director | 08 Oct 2003 | 2003 | ₹53.20 Cr (FY 2025) | Active |
 Rineus Health Care Company Private Limited U24230KL2012PTC031219 | Director | 05 Mar 2013 | 2012 | ₹8.76 Cr (FY 2025) | Active |
| Renolife Pharma (India) Private Limited U52310KL2008PTC023384 | Director | 11 Jun 2010 | 2008 | ₹7.51 Cr (FY 2024) | Active |
| Rhine Life Sciences Private Limited U24232KL2006PTC019505 | Director | 08 Jun 2006 | 2006 | ₹5.14 Cr (FY 2025) | Active |
 R-Vision Eye Hospital Private Limited U85100KL2019PTC056944 | Director | 22 Feb 2019 | 2019 | ₹4.42 Cr (FY 2025) | Active |
Board colleagues of Tirunilayi Krishnan Venugopal
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Tirunilayi Krishnan Venugopal
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Tirunilayi Krishnan Venugopal
Tirunilayi Krishnan Venugopal currently holds 5 directorships: Rhine Biogenics Private Limited (Managing Director, since 08 Oct 2003, revenue ₹53.20 Cr (FY 2025)); Rineus Health Care Company Private Limited (Director, since 05 Mar 2013, revenue ₹8.76 Cr (FY 2025)); Renolife Pharma (India) Private Limited (Director, since 11 Jun 2010, revenue ₹7.51 Cr (FY 2024)); Rhine Life Sciences Private Limited (Director, since 08 Jun 2006, revenue ₹5.14 Cr (FY 2025)); R-Vision Eye Hospital Private Limited (Director, since 22 Feb 2019, revenue ₹4.42 Cr (FY 2025)).
Tirunilayi Krishnan Venugopal was first appointed on 08 Oct 2003 as Managing Director at Rhine Biogenics Private Limited. The most recent appointment on record is 22 Feb 2019 at R-Vision Eye Hospital Private Limited.
The 5 current companies of Tirunilayi Krishnan Venugopal that report revenue have a combined latest revenue of ₹79.04 Cr: Rhine Biogenics Private Limited ₹53.20 Cr (FY 2025); Rineus Health Care Company Private Limited ₹8.76 Cr (FY 2025); Renolife Pharma (India) Private Limited ₹7.51 Cr (FY 2024); Rhine Life Sciences Private Limited ₹5.14 Cr (FY 2025); R-Vision Eye Hospital Private Limited ₹4.42 Cr (FY 2025).
The current boards of Tirunilayi Krishnan Venugopal's companies include Ajith Sukumaran Nair (Rhine Biogenics Private Limited), Ajitkumar Warrior (Rhine Biogenics Private Limited), Jayakumar Narayanan Nair (Rhine Biogenics Private Limited), Kallungal Unni Jothish (Rhine Biogenics Private Limited), Madathiveetil Ramesh (Rhine Biogenics Private Limited), Peter Jose Ansal Parriathcherry (Rhine Biogenics Private Limited), among others.